American Century Companies’s Ligand Pharmaceuticals LGND Stock Holding History

American Century Companies’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.08M	Sell	40,495 -390	-1%	-$77.2K	﹤0.01%	1555
2025 Q4	$7.73M	Sell	40,885 -4,717	-10%	-$906K	﹤0.01%	1564
2025 Q3	$8.08M	Buy	45,602 +1,023	+2%	+$152K	﹤0.01%	1510
2025 Q2	$5.07M	Buy	44,579 +4,123	+10%	+$441K	﹤0.01%	1662
2025 Q1	$4.25M	Buy	40,456 +3,219	+9%	+$364K	﹤0.01%	1671
2024 Q4	$3.99M	Buy	37,237 +2,381	+7%	+$269K	﹤0.01%	1702
2024 Q3	$3.49M	Buy	34,856 +5,689	+20%	+$573K	﹤0.01%	1742
2024 Q2	$2.46M	Buy	29,167 +4,104	+16%	+$327K	﹤0.01%	1825
2024 Q1	$1.83M	Buy	25,063 +6,008	+32%	+$443K	﹤0.01%	1922
2023 Q4	$1.36M	Sell	19,055 -34,520	-64%	-$2.04M	﹤0.01%	1949
2023 Q3	$3.21M	Sell	53,575 -12,896	-19%	-$849K	﹤0.01%	1506
2023 Q2	$4.79M	Sell	66,471 -373	-0.6%	-$28K	﹤0.01%	1328
2023 Q1	$4.77M	Sell	66,844 -1,255	-2%	-$89.2K	﹤0.01%	1278
2022 Q4	$4.55M	Sell	68,099 -1,038	-2%	-$67.5K	﹤0.01%	1256
2022 Q3	$3.71M	Buy	+69,137	New	+$4.06M	﹤0.01%	1221
2022 Q1	–	Sell	-2,558	Closed	-$247K	–	2329
2021 Q4	$247K	Buy	2,558 +195	+8%	+$18K	﹤0.01%	2145
2021 Q3	$205K	Buy	+2,363	New	+$183K	﹤0.01%	2182
2019 Q3	–	Sell	-38,017	Closed	-$2.71M	–	1264
2019 Q2	$2.71M	Sell	38,017 -368	-1%	-$27.1K	﹤0.01%	975
2019 Q1	$3.01M	Sell	38,385 -7,595	-17%	-$575K	﹤0.01%	926
2018 Q4	$3.89M	Buy	45,980 +3,582	+8%	+$382K	﹤0.01%	863
2018 Q3	$7.26M	Buy	42,398 +2,996	+8%	+$452K	0.01%	749
2018 Q2	$5.09M	Buy	39,402 +1,079	+3%	+$120K	0.01%	846
2018 Q1	$3.95M	Buy	38,323 +6,050	+19%	+$598K	﹤0.01%	881
2017 Q4	$2.76M	Buy	32,273 +9,049	+39%	+$784K	﹤0.01%	959
2017 Q3	$1.97M	Sell	23,224 -468	-2%	-$37.1K	﹤0.01%	1035
2017 Q2	$1.79M	Sell	23,692 -3,389	-13%	-$237K	﹤0.01%	1054
2017 Q1	$1.79M	Buy	27,081 +3,424	+14%	+$225K	﹤0.01%	1061
2016 Q4	$1.5M	Sell	23,657 -957	-4%	-$60.4K	﹤0.01%	1079
2016 Q3	$1.57M	Sell	24,614 -97,387	-80%	-$7.15M	﹤0.01%	1096
2016 Q2	$9.08M	Sell	122,001 -17,785	-13%	-$1.32M	0.01%	671
2016 Q1	$9.34M	Buy	139,786 +7,633	+6%	+$464K	0.01%	666
2015 Q4	$8.94M	Sell	132,153 -5,891	-4%	-$364K	0.01%	664
2015 Q3	$7.38M	Buy	138,044 +13,478	+11%	+$818K	0.01%	715
2015 Q2	$7.84M	Sell	124,566 -25,848	-17%	-$1.41M	0.01%	729
2015 Q1	$7.24M	Sell	150,414 -22,409	-13%	-$859K	0.01%	734
2014 Q4	$5.74M	Buy	172,823 +26,160	+18%	+$851K	0.01%	827
2014 Q3	$4.3M	Buy	146,663 +132,016	+901%	+$4.38M	0.01%	907
2014 Q2	$569K	Hold	14,647	–	–	﹤0.01%	1310
2014 Q1	$615K	Buy	14,647 +7,185	+96%	+$299K	﹤0.01%	1313
2013 Q4	$245K	Buy	+7,462	New	+$243K	﹤0.01%	1406

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

American Century Companies's LGND Position: Q1 2026 in Review

American Century Companies reduced its Ligand Pharmaceuticals (LGND) stake by 0.95% in Q1 2026, selling an estimated $77.2K and leaving 40,495 shares worth $8.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

American Century Companies first reported a position in LGND in Q4 2013 and has held it in 40 quarters since. The position peaked at $9.34M in Q1 2016. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

American Century Companies held 40,495 shares of Ligand Pharmaceuticals worth $8.08M as of Q1 2026.
American Century Companies sold 390 Ligand Pharmaceuticals shares in Q1 2026, an estimated $77.2K.
Ligand Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1555 holding.
American Century Companies first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 40 quarters since.
American Century Companies's Ligand Pharmaceuticals position peaked at $9.34M in Q1 2016.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.